ERSP Reviews Advertising For Iovate “Smartburn”
New York, NY – September 5, 2006 – The Electronic Retailing Self-Regulation Program (ERSP) announced that Iovate Health Sciences International (Iovate), marketers of the SmartBurn with Hoodia Weight Loss Supplement (SmartBurn), have provided a reasonable basis for all general performance and establishment claims as well as doctor and consumer testimonial claims. ERSP has recommended the marketer modify certain claims. The marketer’s advertising was reviewed pursuant to an anonymous challenge.
ERSP, the electronic direct-response industry’s self-regulatory forum, is administered by the Council of Better Business Bureaus (CBBB) with policy oversight by the National Advertising Review Council (NARC). ERSP reviewed core claims that include:
- “Two published, 8-week, double-blind clinical studies show that with the key ingredients in SmartBurn, you can lose up to 450 percent of the weight than if you were to follow a diet and exercise plan alone. “
- “Rapid Weight Loss for Women”
- “Whether it’s your belly, thighs, or buttocks, troublesome spots won’t be a problem because SmartBurn helps you achieve rapid total-body weight loss.”
- “I went from a size 10 to a size 4 in just 12 weeks…” “Kimberly lost 22 pounds thanks to SmartBurn with Hoodia.” “Stressed out? … SmartBurn with Hoodia is a scientific weight-loss
- breakthrough with ingredients that burn fat . . . while promoting relaxation to help you manage stress.” (Dr. Jennifer R. Glover)
Following its review of the evidence, which included two well-designed, peer reviewed, double blinded, placebo controlled studies that resulted in statistically significant data, ERSP determined that the marketer provided adequate support for Iovate’s establishment claims and a sufficient basis for its claim of appetite control. However, ERSP also determined that the advertising, without certain modifications, when viewed as whole, could be interpreted by consumers as communicating “targeted” weight-loss claims.
ERSP concluded that while there is some question whether the weight loss demonstrated in the studies would be consistent with consumer expectations of claims of “rapid” weight loss, ERSP was satisfied that consumers would understand the time of product performance being relied on by the marketer in making the claim
ERSP determined that the exclusivity claim as communicated could be ambiguously interpreted by consumers as communicating the unsupported message that SmartBurn is “the world’s first powerful and effective weight-loss product” that additionally provides a stress management benefit as well.
Regarding the consumer testimonial claims, it was determined that the statement that “Kimberly lost 22 pounds thanks to SmartBurn with Hoodia” was supported because the weight loss was within range of the results reported in the studies.
Lastly, ERSP determined that Iovate’s claim that SmartBurn is “doctor formulated” was sufficiently supported and that Dr. Glover’s endorsement of SmartBurn was appropriate.
In response to ERSP’s findings, Iovate stated it “… appreciates ERSP’s careful consideration of the relevant science and its conclusion that the principal weight loss claims for SmartBurn are substantiated by competent and reliable scientific evidence. Iovate will closely consider ERSP’s recommendations on the secondary claims and changes to future advertising that are consistent with this decision.”
Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.
Latest Decisions
NAD Finds Certain Claims for Mott’s Fruit Flavored Snacks Supported or Outside NAD’s Jurisdiction; Recommends General Mills Discontinue or Modify Other Claims
New York, NY – November 25, 2024 – The National Advertising Division recommended that General Mills discontinue or modify certain express and implied claims regarding the fruit and vegetable content of Mott’s Fruit Flavored Snacks and the nutritional benefits of those ingredients.
In National Advertising Division Challenge, Drip Hydration Voluntarily Discontinues Claims for its Ketamine IV Therapy
New York, NY – November 22, 2024 – Following a challenge brought by the National Advertising Division as part of its routine monitoring program, Drip Hydration voluntarily discontinued advertising claims for its Drip Hydration Ketamine IV Therapy.
NAD Finds Patented and Safety Claims for POOPH’s Pet Odor & Stain Eliminator Supported; Recommends Other Claims Be Modified or Discontinued
New York, NY – November 21, 2024 – The National Advertising Division determined that Ikigai supported patented and safety claims for their POOPH Pet Odor & Stain Eliminator, but recommended that other claims, including claims that POOPH eliminates odors and strains, be discontinued.
National Advertising Division Recommends SharkNinja Discontinue Certain Best Deep Carpet Cleaning Claims
New York, NY – November 19, 2024 – BBB National Programs’ National Advertising Division recommended that SharkNinja discontinue the claim “The Best Deep Carpet Cleaning Among Full-Sized Deep Carpet Cleaners** Based on ASTM F2828 vs. full-sized carpet cleaners above 14 lbs.”